Skip to search boxSkip to navigationSkip to main content

Is Cardiopulmonary Resuscitation Futile in Coronavirus Disease 2019 Patients Experiencing In-Hospital Cardiac Arrest?

  • Priyank Shah(corresponding author)
    ,
  • Hallie Smith
    ,
  • Ayodeji Olarewaju
    ,
  • Yash Jani
    ,
  • Abigail Cobb
    ,
  • Jack Owens
*Corresponding author for this work
  • Augusta University
    ,
  • Phoebe Putney Memorial Hospital
    ,
  • Mercer University
    ,
  • ,
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Objectives: There is limited data regarding outcomes after in-hospital cardiac arrest among coronavirus disease 2019 patients. None of the studies have reported the outcomes of in-hospital cardiac arrest in coronavirus disease 2019 patients in the United States. We describe the characteristics and outcomes of in-hospital cardiac arrest in coronavirus disease 2019 patients in rural Southwest Georgia. Design: Retrospective cohort study. Setting: Single-center, multihospital. PATIENTS: Consecutive coronavirus disease 2019 patients who experienced in-hospital cardiac arrest with attempted resuscitation. Interventions: Attempted resuscitation with advanced cardiac life support. Measurement and Main Results: Out of 1,094 patients hospitalized for coronavirus disease 2019 during the study period, 63 patients suffered from in-hospital cardiac arrest with attempted resuscitation and were included in this study. The median age was 66 years, and 49.2% were males. The majority of patients were African Americans (90.5%). The most common comorbidities were hypertension (88.9%), obesity (69.8%), diabetes (60.3%), and chronic kidney disease (33.3%). Eighteen patients (28.9%) had a Charlson Comorbidity Index of 0-2. The most common presenting symptoms were shortness of breath (63.5%), fever (52.4%), and cough (46%). The median duration of symptoms prior to admission was 14 days. During hospital course, 66.7% patients developed septic shock, and 84.1% had acute respiratory distress syndrome. Prior to in-hospital cardiac arrest, 81% were on ventilator, 60.3% were on vasopressors, and 39.7% were on dialysis. The majority of in-hospital cardiac arrest (84.1%) occurred in the ICU. Time to initiation of advanced cardiac life support protocol was less than 1 minute for all in-hospital cardiac arrest in the ICU and less than 2 minutes for the remaining patients. The most common initial rhythms were pulseless electrical activity (58.7%) and asystole (33.3%). Although return of spontaneous circulation was achieved in 29% patients, it was brief in all of them. The in-hospital mortality was 100%. Conclusions: In our study, coronavirus disease 2019 patients suffering from in-hospital cardiac arrest had 100% in-hospital mortality regardless of the baseline comorbidities, presenting illness severity, and location of arrest.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 201-208 (8 pages)

Journal (Volume, Issue Number)

Critical care medicine (Volume 49, Issue 2)

Publication milestones

  • Accepted/In press - 2021
  • Published - 02/01/2021

Publication status

Published - 02/01/2021

ISSN

0090-3493

Publication IDs

  • Scopus: 85100070139
  • PubMed: 33093278

Publication metrics

Metrics

SciVal
citations
12
SciVal
FWCI
22.76
SciVal
Author count
9
SciVal
Paper percentile
99
SciVal
Top percentile
1
Fractional count
2
Fractional count
0.22
Fractional count
7
Fractional count
0.78
Fractional count
2
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
51
Captures
123

Funding Details

Dr. Smith received funding from the Medical College of Georgia. Dr. Hess received funding from Athersys (royalties) and Aruna, and he received support for article research from the National Institutes of Health. The remaining authors have disclosed that they do not have any potential conflicts of interest.
FundersFunding number
NIH
-
NIMHD
K01MD015304
MCG
-